Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Background Several randomized controlled trials (RCTs) have already shown that paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and target lesion revascularization after lower extremity interventions. Methods and Results A systematic review and meta‐analysis...
Main Authors: | Konstantinos Katsanos, Stavros Spiliopoulos, Panagiotis Kitrou, Miltiadis Krokidis, Dimitrios Karnabatidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.118.011245 |
Similar Items
-
A case of vasculitis after paclitaxel drug-coated balloon angioplasty
by: Kelly Hawkins, BS, et al.
Published: (2022-05-01) -
Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty
by: Allison Montgomery, BA, et al.
Published: (2018-01-01) -
Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01) -
ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
by: Ilka Ott, et al.
Published: (2017-07-01) -
Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
by: Rajesh V. Swaminathan, et al.
Published: (2019-05-01)